{"id":414611,"date":"2021-01-14T02:43:21","date_gmt":"2021-01-14T07:43:21","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=414611"},"modified":"2021-01-14T02:43:21","modified_gmt":"2021-01-14T07:43:21","slug":"neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\/","title":{"rendered":"NeoDynamics will be granted another European patent for its pulse biopsy tools"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">STOCKHOLM<\/span>, <span class=\"xn-chron\">Jan. 14, 2021<\/span> \/PRNewswire\/ &#8212; NeoDynamics AB (Spotlight Stock Market: NEOD), a MedTech company dedicated to advancing diagnosis and care of breast cancer, today announces that the European Patent Office (EPO) has issued a Communication under Rule 71(3) EPC (Notice of Allowance) and intends to grant a European patent for NeoDynamics pulse biopsy tools, including a multi-purpose driver supporting several different needle options. The decision will be published in the European Patent Bulletin, once the requirements concerning the translation of the claims and payment of all fees are fulfilled by NeoDynamics.<\/p>\n<p>&#8220;This is very exciting and supports our launch of the pulse biopsy system NeoNavia, including three needle options for all ultrasound led biopsy procedures. This will reinforce our patent position in <span class=\"xn-location\">Europe<\/span>. We continue to develop our portfolio of proprietary assets to further expand our business opportunities and to support our product.&#8221;, says <span class=\"xn-person\">Anna Eriksrud<\/span>, CEO NeoDynamics. &#8220;The pioneering biopsy system has already gained significant interest, and we have managed to receive the first commercial orders, despite the challenging business environment following the pandemic. Ultrasound guided biopsy in breast and axilla is perceived as critical to ensure an early and adequate diagnosis and ultimately improve patient outcomes&#8221;.<\/p>\n<p>\n        <b>CONTACT: <\/b>\n      <\/p>\n<p>For additional information please contact:<\/p>\n<p>\n        <span class=\"xn-person\">Anna Eriksrud<\/span>, CEO NeoDynamics,\u00a0Phone\u00a0: +46 +46 (0) 708 444 966, e-mail: <a target=\"_blank\" href=\"mailto:anna.eriksrud@neodynamics.com\" rel=\"nofollow noopener noreferrer\">anna.eriksrud@neodynamics.com<\/a><br \/>The information was submitted for publication, on <span class=\"xn-chron\">January 14, 2021<\/span> at 08.30 (CET).<\/p>\n<p>This information was brought to you by Cision <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3037342-1&amp;h=307933996&amp;u=http%3A%2F%2Fnews.cision.com%2F&amp;a=http%3A%2F%2Fnews.cision.com\" rel=\"nofollow noopener noreferrer\">http:\/\/news.cision.com<\/a><\/p>\n<p>\n        <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3037342-1&amp;h=2140352833&amp;u=https%3A%2F%2Fnews.cision.com%2Fneodynamics%2Fr%2Fneodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools%2Cc3267686&amp;a=https%3A%2F%2Fnews.cision.com%2Fneodynamics%2Fr%2Fneodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools%2Cc3267686\" rel=\"nofollow noopener noreferrer\">https:\/\/news.cision.com\/neodynamics\/r\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools,c3267686<\/a>\n      <\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO48722&amp;sd=2021-01-14\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools-301208191.html\">http:\/\/www.prnewswire.com\/news-releases\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools-301208191.html<\/a><\/p>\n<p>SOURCE  NeoDynamics<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=IO48722&amp;Transmission_Id=202101140239PR_NEWS_USPR_____IO48722&amp;DateId=20210114\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire STOCKHOLM, Jan. 14, 2021 \/PRNewswire\/ &#8212; NeoDynamics AB (Spotlight Stock Market: NEOD), a MedTech company dedicated to advancing diagnosis and care of breast cancer, today announces that the European Patent Office (EPO) has issued a Communication under Rule 71(3) EPC (Notice of Allowance) and intends to grant a European patent for NeoDynamics pulse biopsy tools, including a multi-purpose driver supporting several different needle options. The decision will be published in the European Patent Bulletin, once the requirements concerning the translation of the claims and payment of all fees are fulfilled by NeoDynamics. &#8220;This is very exciting and supports our launch of the pulse biopsy system NeoNavia, including three needle options for all ultrasound led biopsy procedures. This will &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;NeoDynamics will be granted another European patent for its pulse biopsy tools&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-414611","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NeoDynamics will be granted another European patent for its pulse biopsy tools - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NeoDynamics will be granted another European patent for its pulse biopsy tools - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire STOCKHOLM, Jan. 14, 2021 \/PRNewswire\/ &#8212; NeoDynamics AB (Spotlight Stock Market: NEOD), a MedTech company dedicated to advancing diagnosis and care of breast cancer, today announces that the European Patent Office (EPO) has issued a Communication under Rule 71(3) EPC (Notice of Allowance) and intends to grant a European patent for NeoDynamics pulse biopsy tools, including a multi-purpose driver supporting several different needle options. The decision will be published in the European Patent Bulletin, once the requirements concerning the translation of the claims and payment of all fees are fulfilled by NeoDynamics. &#8220;This is very exciting and supports our launch of the pulse biopsy system NeoNavia, including three needle options for all ultrasound led biopsy procedures. This will &hellip; Continue reading &quot;NeoDynamics will be granted another European patent for its pulse biopsy tools&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-14T07:43:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO48722&amp;sd=2021-01-14\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"NeoDynamics will be granted another European patent for its pulse biopsy tools\",\"datePublished\":\"2021-01-14T07:43:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\\\/\"},\"wordCount\":268,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO48722&amp;sd=2021-01-14\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\\\/\",\"name\":\"NeoDynamics will be granted another European patent for its pulse biopsy tools - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO48722&amp;sd=2021-01-14\",\"datePublished\":\"2021-01-14T07:43:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO48722&amp;sd=2021-01-14\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO48722&amp;sd=2021-01-14\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NeoDynamics will be granted another European patent for its pulse biopsy tools\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NeoDynamics will be granted another European patent for its pulse biopsy tools - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\/","og_locale":"en_US","og_type":"article","og_title":"NeoDynamics will be granted another European patent for its pulse biopsy tools - Market Newsdesk","og_description":"PR Newswire STOCKHOLM, Jan. 14, 2021 \/PRNewswire\/ &#8212; NeoDynamics AB (Spotlight Stock Market: NEOD), a MedTech company dedicated to advancing diagnosis and care of breast cancer, today announces that the European Patent Office (EPO) has issued a Communication under Rule 71(3) EPC (Notice of Allowance) and intends to grant a European patent for NeoDynamics pulse biopsy tools, including a multi-purpose driver supporting several different needle options. The decision will be published in the European Patent Bulletin, once the requirements concerning the translation of the claims and payment of all fees are fulfilled by NeoDynamics. &#8220;This is very exciting and supports our launch of the pulse biopsy system NeoNavia, including three needle options for all ultrasound led biopsy procedures. This will &hellip; Continue reading \"NeoDynamics will be granted another European patent for its pulse biopsy tools\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-14T07:43:21+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO48722&amp;sd=2021-01-14","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"NeoDynamics will be granted another European patent for its pulse biopsy tools","datePublished":"2021-01-14T07:43:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\/"},"wordCount":268,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO48722&amp;sd=2021-01-14","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\/","name":"NeoDynamics will be granted another European patent for its pulse biopsy tools - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO48722&amp;sd=2021-01-14","datePublished":"2021-01-14T07:43:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO48722&amp;sd=2021-01-14","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO48722&amp;sd=2021-01-14"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/neodynamics-will-be-granted-another-european-patent-for-its-pulse-biopsy-tools\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"NeoDynamics will be granted another European patent for its pulse biopsy tools"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/414611","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=414611"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/414611\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=414611"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=414611"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=414611"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}